Table 5 Results of binomial logistic regression analysis for risk factors of postoperative RVH

Sex (male/female)

1.355 (0.440–4.176)

0.597

4.226 (0.476–37.514)

0.196

0.767 (0.277–2.120)

0.609

2.509 (0.348–18.093)

0.361

Age, years

0.927 (0.877–0.980)

0.008

0.894 (0.814–0.982)

0.019

0.925 (0.881–0.970)

0.001

0.888 (0.819–0.963)

0.004

Duration of diabetes, years

0.872 (0.784–0.971)

0.012

0.833 (0.697–0.997)

0.046

0.888 (0.814–0.968)

0.007

0.835 (0.716–0.972)

0.02

Preoperative fasting blood glucose level

0.784 (0.586–1.048)

0.101

0.928 (0.628–1.371)

0.708

1.068 (0.887–1.287)

0.488

1.182 (0.851–1.640)

0.319

Preoperative systolic blood pressure

1.005 (0.976–1.035)

0.745

1.019 (0.969–1.072)

0.467

1.013 (0.989–1.037)

0.304

0.993 (0.948–1.041)

0.783

Serum creatinine, μmol/L

1.013 (1.002–1.024)

0.02

1.028 (1.008–1.049)

0.006

1.006 (1.002–1.010)

0.004

1.009 (1.000–1.019)

0.042

Blood urea

0.995 (0.972–1.019)

0.703

0.986 (0.929–1.046)

0.637

1.285 (1.107–1.491)

0.001

1.226 (0.968–1.553)

0.09

Triamcinolone acetonide usage

0.417 (0.084–2.075)

0.285

0.626 (0.057–6.861)

0.701

1.378 (0.499–3.806)

0.536

3.777 (0.512–27.84)

0.192

Electral-coagulation usage (fibrovascular membrane)

0.525 (0.104–2.663)

0.437

1.103 (0.057–21.471)

0.948

0.583 (0.066–5.132)

0.627

0.187 (0.006–6.260)

0.349

Air-fluid exchange

1.041(.101–10.692)

0.973

0.156 (0.005–5.348)

0.303

0.923 (0.330–2.581)

0.879

0.858 (0.124–5.934)

0.876

Pre-pan-retinal photocoagulation

0.956 (0.228–4.004)

0.95

2.350 (0.221–25.009)

0.479

0.221 (0.027–1.791)

0.157

0.109 (0.008–1.528)

0.1

Anti-vascular endothelial growth drug usage

0.281 (0.033–2.391)

0.245

0.083 (0.003–2.690)

0.161

1.255 (0.461–3.420)

0.657

0.456 (0.074–2.795)

0.396